MART 1 peptide

Germline-governed Recognition Of A Cancer Epitope By An Immunodominant Human T Cell Receptor Chain C

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-008

Synonyms/Alias:Germline-governed Recognition Of A Cancer Epitope By An Immunodominant Human T Cell Receptor Chain C (1-10)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
ELAGIGILTV
Areas of Interest
Antigen-presenting Cells; Cancer Research
Source#
Homo sapiens (human)
Epitope
1-10
Restricting HLA
HLA-A2
References
Natacha Merindol;J Immunol 2010

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOcGMP Peptide ServiceEpitope Mapping ServicesPeptide Analysis ServicesPeptide Synthesis ServicesCustom Conjugation ServicePeptide Modification ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers